CODX

0.78

7.94% 0.0574

Dopo l'orario di chiusura: .80 0.02 +2.56%

Co Diagnostics Inc (CODX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$0.7226

Aprire:

$0.728

Volume 24 ore:

350.97K

Relative Volume:

2.50

Capitalizzazione di mercato:

$24.91M

Reddito:

$7.11M

Utile/perdita netta:

$-41.28M

Rapporto P/E:

-0.5652

EPS:

-1.38

Flusso di cassa netto:

$-26.84M

1 W Prestazione:

+6.85%

1M Prestazione:

-11.36%

6M Prestazione:

-39.06%

1 anno Prestazione:

-43.48%

Intervallo 1D:

$0.728

$0.79

Intervallo di 1 settimana:

$0.67

$0.79

Portata 52W:

$0.67

$2.2299

Co Diagnostics Inc Stock (CODX) Company Profile

Nome

Co Diagnostics Inc

Settore

Healthcare (1174)

Industria

Medical Devices (149)

Telefono

(801) 278-9769

Indirizzo

4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY

Dipendente

155

Cinguettio

@Co_Diagnostics

Prossima data di guadagno

2024-11-07

Ultimi documenti SEC

CODX's Discussions on Twitter

Confronta CODX con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CODX Co Diagnostics Inc	0.78	24.91M	7.11M	-41.28M	-26.84M	-1.38
ABT Abbott Laboratories	113.83	197.43B	41.22B	5.77B	6.49B	3.29
SYK Stryker Corp	361.52	137.82B	21.97B	3.59B	3.21B	9.33
BSX Boston Scientific Corp	90.69	133.66B	15.91B	1.79B	1.89B	1.21
MDT Medtronic Plc	80.95	103.80B	33.00B	4.29B	5.50B	3.27
EW Edwards Lifesciences Corp	73.91	43.59B	6.60B	4.16B	490.10M	6.93

Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2022-08-12	Downgrade	Sidoti	Buy → Neutral
2021-12-29	Iniziato	Sidoti	Buy
2021-03-29	Downgrade	Maxim Group	Buy → Hold
2020-05-20	Aggiornamento	Maxim Group	Hold → Buy
2020-05-18	Reiterato	H.C. Wainwright	Buy
2020-03-09	Reiterato	H.C. Wainwright	Buy
2020-03-03	Downgrade	Maxim Group	Buy → Hold

Mostra tutto

Co Diagnostics Inc Borsa (CODX) Ultime notizie

Dec 30, 2024

Co-Diagnostics stock plunges to 52-week low at $0.69 By Investing.com - Investing.com Canada

Dec 30, 2024

Co-Diagnostics (NASDAQ:CODX) and Aethlon Medical (NASDAQ:AEMD) Critical Review - Defense World

Dec 30, 2024

Dec 24, 2024

Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Rele - GuruFocus.com

Dec 24, 2024

Dec 19, 2024

Financial Review: Co-Diagnostics (NASDAQ:CODX) & Endologix (OTCMKTS:ELGXQ) - Defense World

Dec 19, 2024

Dec 16, 2024

Co-Diagnostics stock hits 52-week low at $0.79 amid market challenges - Investing.com

Dec 16, 2024

Dec 13, 2024

CoSara Diagnostics inaugurates new oligo facility in Ranoli, Gujarat - BSI bureau

Dec 13, 2024

Dec 12, 2024

Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility - Marketscreener.com

Dec 12, 2024

Dec 11, 2024

Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast - The Eastern Progress Online

Dec 11, 2024

Co-Diagnostics, Inc. to Accompany Utah Governor and WTC Utah on Trade Mission to South Korea and Japan - The Eastern Progress Online

Dec 11, 2024

Dec 10, 2024

Telugu News, Tollywood News, Andhra, Telangana, Southఇండియా హెరాల్డ్ గ్రూప్ అఫ్ పబ్లిషర్స్ ప్రై లిమిటెడ్ - ఇండియా హెరాల్డ్ గ్రూప్ అఫ్ పబ్లిషర్స్ ప్రై లిమిటెడ్ - India Herald Group of Publishers P LIMITED

Dec 10, 2024

Dec 06, 2024

Co-Diagnostics stock hits 52-week low at $0.85 amid market challenges - Investing.com Canada

Dec 06, 2024

Dec 05, 2024

Co-Diagnostics (FRA:C97) Earnings Yield % : N/A% (As of Dec. 05, 2024) - GuruFocus.com

Dec 05, 2024

Co-Diagnostics (FRA:C97) Enterprise Value : €-6.97 Mil (As of Dec. 05, 2024) - GuruFocus.com

Dec 05, 2024

Co-Diagnostics (STU:C97) Momentum Rank : 7 (As of Dec. 05, 2024) - GuruFocus.com

Dec 05, 2024

Dec 01, 2024

Co-Diagnostics (FRA:C97) EBITDA per Share : €-1.18 (TTM As of Sep. 2024) - GuruFocus.com

Dec 01, 2024

Co-Diagnostics (FRA:C97) 3-Year FCF Growth Rate : 0.00% (As of Sep. 2024) - GuruFocus.com

Dec 01, 2024

Co-Diagnostics (HAM:C97) Price-to-Operating-Cash-Flow : (As of Dec. 01, 2024) - GuruFocus.com

Dec 01, 2024

Nov 30, 2024

Co-Diagnostics (HAM:C97) 50-Day SMA : €1.07 (As of Nov. 30, 2024) - GuruFocus.com

Nov 30, 2024

Nov 29, 2024

Rabies Diagnostics Market Report Details Trends and Growth Analysis Report 2024 - WhaTech

Nov 29, 2024

Nov 27, 2024

Co-Diagnostics (HAM:C97) Cash Flow from Operations : €-23.54 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 27, 2024

Co-Diagnostics (HAM:C97) Forward Rate of Return (Yacktman) % : 0.00% (As of Sep. 2024) - GuruFocus.com

Nov 27, 2024

Co-Diagnostics (HAM:C97) Change In Inventory : €0.32 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 27, 2024

Co-Diagnostics (HAM:C97) Forward Dividend Yield % : 0.00% (As of Nov. 26, 2024) - GuruFocus.com

Nov 27, 2024

Nov 26, 2024

CODX (Co-Diagnostics) 3-Year Book Growth Rate : 5.60% (As of Sep. 2024) - GuruFocus.com

Nov 26, 2024

Co-Diagnostics stock hits 52-week low at $1 amid market challenges - Investing.com Australia

Nov 26, 2024

CODX (Co-Diagnostics) Momentum Rank : 8 (As of Nov. 26, 2024) - GuruFocus.com

Nov 26, 2024

Co-Diagnostics, Inc. to Host Booth at the 2024 UHCA/UCAL Fall Convention & Expo on Oct 2-3 - GuruFocus.com

Nov 26, 2024

Co-Diagnostics stock hits 52-week low at $1 amid market challenges By Investing.com - Investing.com South Africa

Nov 26, 2024

Nov 25, 2024

CODX (Co-Diagnostics) 3-Year EPS without NRI Growth Rate : 0.00% (As of Sep. 2024) - GuruFocus.com

Nov 25, 2024

Nov 24, 2024

Co-Diagnostics (HAM:C97) Cash Flow from Discontinued Operat - GuruFocus.com

Nov 24, 2024

Nov 22, 2024

Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results - GuruFocus.com

Nov 22, 2024

Nov 21, 2024

Co-Diagnostics (LTS:0A50) Total Liabilities : $8.60 Mil (As of Sep. 2024) - GuruFocus.com

Nov 21, 2024

Nov 18, 2024

Daxor (NASDAQ:DXR) & Co-Diagnostics (NASDAQ:CODX) Critical Survey - Defense World

Nov 18, 2024

Nov 14, 2024